Anti-inflammatory treatment using alpha melanocyte stimulating hormone (α-MSH) does not alter osteoblasts differentiation and fracture healing
Abstract Background Alpha-melanocyte-stimulating-hormone (α-MSH) has been identified as a new anti-inflammatory treatment compound in rheumatoid arthritis (RA) and other inflammatory diseases. However, its direct effect on bone cell differentiation or on bone regeneration, which is an inflammatory p...
Saved in:
Main Authors: | Johanna Graue, Melanie Timmen, Katharina Schmitz, Daniel Kronenberg, Markus Böhm, Kishor K. Sivaraj, M. Gabriele Bixel, Richard Stange |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12891-025-08374-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Role of α-MSH in Colitis Progression: Mediating Neutrophil Differentiation via Bone Marrow
by: Liao X, et al.
Published: (2025-02-01) -
Clinicopathological features of Lynch syndrome pedigrees with MSH2 c.351G>A gene variant
by: Shuai Zhang, et al.
Published: (2025-01-01) -
Jingui Shenqi Wan alleviates bone loss induced by primary osteoporosis by inhibiting osteoblast pyroptosis
by: Yuwangxuan Qian, et al.
Published: (2025-02-01) -
Modeling of the kinetics of vitamin D$_3$ in osteoblastic cells
by: Robert P. Gilbert, et al.
Published: (2012-12-01) -
B-doped nano-hydroxyapatite facilitates proliferation and differentiation of osteoblasts
by: Qiao Kang, et al.
Published: (2025-01-01)